CAS: 2561414-56-8
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide REF: IN-DA023ODRCAS: 2561414-56-8 | 98% | A consultar | Qui 02 Jan 25 |
 | GNF2133 REF: TM-T40187CAS: 2561414-56-8 | 98.11% | 125,00 €~1.606,00 € | Qui 02 Jan 25 |
![4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1…](https://static.cymitquimica.com/products/IN/thumb/DA023ODR.jpg)
4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide
CAS:2561414-56-8
Fórmula:
C24H30N6O2
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
434.5340
Ref: IN-DA023ODR
| 5mg | 181,00 € | ||
| 10mg | 323,00 € | ||
| 25mg | 635,00 € | ||
| 50mg | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 2 de Janeiro de 2025
GNF2133
CAS:2561414-56-8
GNF2133 is an effective and selective inhibitor of DYRK1A with IC50s of 6.2 nM. GNF2133 …
Fórmula:
C24H30N6O2
Pureza:
98.11%
Cor e Forma:
Liquid
Peso molecular:
434.53
Ref: TM-T40187
| 1mg | 125,00 € | ||
| 5mg | 300,00 € | ||
| 10mg | 453,00 € | ||
| 25mg | 757,00 € | ||
| 50mg | 1.124,00 € | ||
| 100mg | 1.606,00 € | ||
| 1mL*10mM (DMSO) | 344,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 2 de Janeiro de 2025
